- Newsletter
- November 2025
- 2 Pages
Global
From €118EUR$131USD£103GBP
- Report
- October 2025
- 25 Pages
Italy
From €995EUR$1,186USD£903GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,186USD£903GBP
- Report
- October 2025
- 24 Pages
Saudi Arabia
From €995EUR$1,186USD£903GBP
- Report
- October 2025
- 26 Pages
Taiwan
From €995EUR$1,186USD£903GBP
From €995EUR$1,186USD£903GBP
- Report
- September 2025
- 26 Pages
Canada
From €995EUR$1,186USD£903GBP
- Report
- September 2025
- 25 Pages
Germany
From €995EUR$1,186USD£903GBP
- Report
- September 2025
- 25 Pages
United Kingdom
From €995EUR$1,186USD£903GBP
- Report
- September 2025
- 23 Pages
China
From €995EUR$1,186USD£903GBP
- Report
- September 2025
- 30 Pages
Australia
From €995EUR$1,186USD£903GBP
- Report
- August 2025
- 73 Pages
From €3101EUR$3,450USD£2,720GBP
- Report
- April 2025
- 71 Pages
China
From €1618EUR$1,800USD£1,419GBP
- Report
- April 2025
- 100 Pages
China
From €1618EUR$1,800USD£1,419GBP
- Report
- January 2025
- 24 Pages
India
From €995EUR$1,186USD£903GBP
- Report
- September 2024
- 231 Pages
China
From €3595EUR$4,000USD£3,153GBP
- Report
- July 2024
- 116 Pages
Global
From €4045EUR$4,500USD£3,547GBP
- Report
- March 2024
- 171 Pages
North America
€4490EUR$4,995USD£3,937GBP
- Report
- February 2024
- 380 Pages
Global
€4490EUR$4,995USD£3,937GBP
- Report
- January 2024
- 227 Pages
Global
€4490EUR$4,995USD£3,937GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more